Gilead Sciences
GILD
2,024 hedge funds and large institutions have $119B invested in Gilead Sciences in 2025 Q2 according to their latest regulatory filings, with 188 funds opening new positions, 840 increasing their positions, 734 reducing their positions, and 152 closing their positions.
34% more call options, than puts
Call options by funds: $1.41B | Put options by funds: $1.06B
24% more first-time investments, than exits
New positions opened: 188 | Existing positions closed: 152
14% more repeat investments, than reductions
Existing positions increased: 840 | Existing positions reduced: 734
0.92% more ownership
Funds ownership: 85.5% → 86.42% (+0.92%)
0% more funds holding
Funds holding: 2,014 → 2,024 (+10)
0% less capital invested
Capital invested by funds: $119B → $119B (-$143M)
37% less funds holding in top 10
Funds holding in top 10: 52 → 33 (-19)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.08B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$945M |
| 3 |
JP Morgan Chase
New York
|
+$851M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$574M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$361M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$2.5B |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$771M |
| 3 |
VanEck Associates
New York
|
-$227M |
| 4 |
Bank of New York Mellon
New York
|
-$220M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$201M |
GILD Hedge Fund Activity: Q2 2025 in Review
2,024 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2025, worth a combined $119B — down 0.12% from $119B a quarter earlier.
Buyers outnumbered sellers: 188 funds opened new GILD positions and 152 closed out — a net gain of 36 holders — while 840 added to existing stakes and 734 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $1.08B. The largest seller was Capital Research Global Investors, cutting an estimated $2.5B.
- 2,024 institutional investors held Gilead Sciences (GILD) as of Q2 2025, up from 2,014 in Q1 2025.
- Funds reported $119B of Gilead Sciences stock for Q2 2025, down 0.12% quarter-over-quarter.
- 188 funds opened new Gilead Sciences positions in Q2 2025 and 152 closed out, a net change of +36 holders.
- The largest Gilead Sciences buyer in Q2 2025 was Wellington Management Group, an estimated $1.08B added.
- The largest Gilead Sciences seller in Q2 2025 was Capital Research Global Investors, an estimated $2.5B sold.
Based on aggregated 13F filings for Q2 2025.